Cellular immunotherapy sector is active, with Tri-gene increasing more than 12%.

The cell immunotherapy sector is relatively active, with three gene stocks surging by over 12%, and related stocks such as Yuekang Pharmaceutical, Sunshine Nuoheng, Zhaoyan New Drugs, Rongchang Biological, Haite Biological, etc., following suit.